Outcomes and Risk Factors for Graft Loss: Lessons Learned from 1,056 Pediatric Kidney Transplants at the University of Minnesota
Authors:
- Srinath ChinnakotlaSCSrinath Chinnakotla
- Michelle N. RheaultMRMichelle N. Rheault
- Ty DunnTDTy Dunn
- Youngki KimYKYoungki Kim
- Lydia NajeraLNLydia Najera
- 1 April 2017
- journal article
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 224 (4) , 473-486
Abstract
Advances in immunosuppression, surgical techniques, and management of infections in children receiving kidney transplants have affected outcomes. We analyzed a prospectively maintained database of pediatric kidney transplantations. From June 1963 through October 2016, we performed 1,056 pediatric kidney transplantations. Of these, 129 were in children less than 2 years old. The most common indications for transplant were congenital anomalies (dysplastic kidneys), obstructive uropathy, and congenital nephrotic syndrome. Living donors constituted 721 (68%) of all donors. The graft and patient survival rates remarkably improved for both deceased and living donor recipients (p = 0.001). Currently, graft survival rates for deceased donor recipients are 92% at 1 year, 76% at 5 years, and 57% at 10 years post-transplant; for living donor recipients, 96% at 1 year, 85% at 5 years, and 78% at 10 years. The graft half-life was 19 years in deceased donor recipients, compared with 25 years in living donor recipients (p ≤ 0.001). Acute rejection was the most common cause of graft loss in the first year post-transplant. The following risk factors were associated with an increased risk of graft loss: deceased donor grafts (p = 0.0001), retransplant (p = 0.02), ages 11 to 18 years (p = 0.001) and pre-transplant urologic issues (p = 0.04). Living donor grafts (p ≤ 0.0001) and pre-emptive transplants (p = 0.02) were associated with decreased risks of graft loss. The success rates of pediatric kidney transplants have significantly improved. Pre-emptive kidney transplantation with a living donor graft continues to be superior and should be the choice in children with end-stage renal disease.Keywords
This publication has 31 references indexed in Scilit:
- The BK virus in renal transplant recipients—review of pathogenesis, diagnosis, and treatmentPediatric Nephrology, 2011
- Media Appeals by Pediatric Patients for Living Donors and the Impact on a Transplant CenterTransplantation, 2011
- Pediatric Kidney Transplantation Using a Novel Protocol of Rapid (6-Day) Discontinuation of Prednisone: 2-Year ResultsTransplantation, 2009
- Banff ’05 Meeting Report: Differential Diagnosis of Chronic Allograft Injury and Elimination of Chronic Allograft Nephropathy (’CAN’)American Journal of Transplantation, 2007
- Sirolimus pharmacokinetics in pediatric renal transplant recipients receiving calcineurin inhibitor co‐therapyPediatric Transplantation, 2006
- The Banff 97 working classification of renal allograft pathologyKidney International, 1999
- Cyclosporin Pharmacokinetics in Paediatric Transplant RecipientsClinical Pharmacokinetics, 1997
- Pseudohermaphroditism, glomerulopathy, and Wilms tumor (Drash syndrome): Frequency in end-stage renal failureThe Journal of Pediatrics, 1985
- Undiversion in children with renal failureJournal of Pediatric Surgery, 1984
- Renal Transplantation in Infants and ChildrenAnnals of Surgery, 1971